Published in Br J Cancer on February 10, 2003
Bacterial lymphadenitis at a major referral hospital in France from 2008 to 2012. J Clin Microbiol (2014) 1.63
Lymph node biopsy specimens and diagnosis of cat-scratch disease. Emerg Infect Dis (2006) 1.44
Real-time PCR strategy and detection of bacterial agents of lymphadenitis. Eur J Clin Microbiol Infect Dis (2009) 1.31
Cancer diagnostic assessment programs: standards for the organization of care in Ontario. Curr Oncol (2009) 0.97
Peripheral lymphadenopathy: approach and diagnostic tools. Iran J Med Sci (2014) 0.92
Quantifying the risk of Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a case-control study using electronic records. Br J Gen Pract (2015) 0.91
Quantifying the risk of non-Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a large case-control study using electronic records. Br J Gen Pract (2015) 0.90
Cervical lymphadenopathy: study of 251 patients. Eur Arch Otorhinolaryngol (2014) 0.84
Evaluation of peripheral lymphadenopathy with excisional biopsy: six-year experience. Int J Clin Exp Pathol (2015) 0.80
Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients. Medicine (Baltimore) (2014) 0.77
Histological Surprises in Benign Cytologies after Lymph Node Biopsy-Surgeon's Knife Improving Patient Care. Indian J Surg Oncol (2016) 0.75
Q fever and lymphadenopathy: report of four new cases and review. Eur J Clin Microbiol Infect Dis (2004) 0.75
Uncommon lymphadenopathies of immunopathogenesis can be misinterpreted as malignant diseases. Rheumatol Int (2006) 0.75
Predictive factors for malignancy in patients with persistent cervical lymphadenopathy. Eur Arch Otorhinolaryngol (2015) 0.75
Influence of delay on survival in patients with breast cancer: a systematic review. Lancet (1999) 13.10
Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet (1999) 5.63
Gender differences in the utilization of health care services. J Fam Pract (2000) 5.59
Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey. BMJ (2000) 4.13
Waiting time for breast cancer surgery in Quebec. CMAJ (2001) 2.29
A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ (2001) 2.11
One-stop diagnosis for symptomatic breast disease. Ann R Coll Surg Engl (1995) 1.94
Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer (2001) 1.92
Delay in the diagnosis and outcome of colorectal cancer: a prospective study. Eur J Surg Oncol (1999) 1.91
Impact of delay on diagnosis and treatment of primary lung cancer. Acta Oncol (2002) 1.91
The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ (2002) 1.81
Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ (2001) 1.52
One stop breast clinics--victims of their own success? A prospective audit of referrals to a specialist breast clinic. Eur J Surg Oncol (2000) 1.38
Fine needle aspiration biopsy in the diagnosis of lymphadenopathy in 1,103 patients. Role, limitations and analysis of diagnostic pitfalls. Acta Cytol (1995) 1.30
Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. AJR Am J Roentgenol (2001) 1.21
Supraclavicular masses: results of a series of 309 cases biopsied by fine needle aspiration. Head Neck (1999) 1.07
Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup. J Fam Pract (1988) 1.04
Fine-needle aspiration cytology in the diagnosis of superficial lymphadenopathy: an analysis of 2,418 cases. Diagn Cytopathol (1996) 1.04
Clinical approach to lymphadenopathy. Semin Oncol (1993) 1.04
Lung cancer referral patterns in the former Yorkshire region of the UK. Br J Cancer (2002) 1.02
The clinical investigation of lymphadenopathy in primary care practice. JAMA (1978) 0.99
Lymphadenopathy in a family practice. J Fam Pract (1981) 0.92
Imaging of cervical lymphadenopathy. Semin Ultrasound CT MR (1997) 0.92
Application of a prediction rule to select which patients presenting with lymphadenopathy should undergo a lymph node biopsy. Medicine (Baltimore) (2000) 0.91
Lymph node biopsy for diagnosis: a statistical study. J Surg Oncol (1980) 0.91
Diagnostic value of lymph node fine needle aspiration cytology: an institutional experience of 387 cases observed over a 5-year period. Cytopathology (2000) 0.88
Diagnosis of hematopoietic processes by fine-needle aspiration in conjunction with flow cytometry: A review of 127 cases. Diagn Cytopathol (2001) 0.88
Lymphadenopathy in a family practice: a descriptive study of 249 cases. J Fam Pract (1985) 0.87
An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom. Clin Lab Haematol (2000) 0.85
Detection of occult metastatic lymph nodes in the neck with gray-scale and power Doppler US. Acta Radiol (2001) 0.84
An audit of patient acceptance of one-stop diagnosis for symptomatic breast disease. Eur J Surg Oncol (1998) 0.82
'One-stop' rectal bleeding clinics without routine flexible sigmoidoscopy are unsafe. Ann R Coll Surg Engl (1998) 0.81
The effect of diagnostic delay in patients with Hodgkin's lymphoma. Anticancer Res (1996) 0.81
Investigating lymphadenopathy--report on the first 12 months of the lymph node diagnostic clinic at the Royal Marsden Hospital. Postgrad Med J (2000) 0.79
Three-year evaluation of a rapid-access coloproctology clinic. Dig Surg (2000) 0.79
Validation of a model to identify young patients for lymph node biopsy. JAMA (1986) 0.77
Fine-needle aspiration of lymph nodes: use of flow cytometry immunophenotyping. Pathology (Phila) (1996) 0.77
An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol (1988) 26.07
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet (1999) 18.20
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell (1978) 14.82
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Cancer statistics, 2000. CA Cancer J Clin (2000) 12.32
Cancer statistics, 2001. CA Cancer J Clin (2001) 11.73
Cancer statistics, 1999. CA Cancer J Clin (1999) 9.18
A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav (2000) 6.72
Cancer statistics, 1998. CA Cancer J Clin (1998) 6.26
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Insulin biosynthesis: evidence for a precursor. Science (1967) 5.05
Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. J Natl Cancer Inst (1998) 4.65
Epidemic Diarrhoea and Vomiting. Br Med J (1945) 4.29
Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci (2000) 4.13
Rural background and clinical rural rotations during medical training: effect on practice location. CMAJ (1999) 4.12
Purification of human T and B lymphocytes. J Immunol (1974) 4.00
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol (2002) 3.98
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol (2002) 3.91
Biotechnology awareness study, Part 1: Where scientists get their information. Bull Med Libr Assoc (1991) 3.85
Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract (1996) 3.71
Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med (2001) 3.55
Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry (1990) 3.45
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer (1998) 3.36
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol (2009) 3.33
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol (1983) 3.23
Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry (1991) 3.21
Spatially independent activity patterns in functional MRI data during the stroop color-naming task. Proc Natl Acad Sci U S A (1998) 3.18
Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet (1999) 3.16
Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol (1975) 3.12
The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg (1994) 3.06
Timer: a new objective measure of consultation content and its application to computer assisted consultations. Br Med J (Clin Res Ed) (1986) 3.00
Decoding the ancient Greek astronomical calculator known as the Antikythera Mechanism. Nature (2006) 2.92
Computer assisted screening: effect on the patient and his consultation. Br Med J (Clin Res Ed) (1985) 2.76
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol (1997) 2.71
Cell surface markers for human T and B lymphocytes. Eur J Immunol (1974) 2.70
Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. American Heart Association. Circulation (1997) 2.68
Protection, pathogenesis and phenotypic plasticity in Plasmodium falciparum malaria. Parasitol Today (1993) 2.64
The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters. Neurology (2011) 2.51
Complications of use of intrauterine devices among HIV-1-infected women. Lancet (1998) 2.50
An encyclopedia of mouse genes. Nat Genet (1999) 2.48
Radiographic interpretation by nurse practitioners in a minor injuries unit. J Accid Emerg Med (1996) 2.44
Computers in the surgery. The patient's view. Br Med J (Clin Res Ed) (1984) 2.43
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol (2005) 2.41
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 2.31
Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol (2000) 2.29
Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. BJU Int (2003) 2.29
Optimal total mesorectal excision for rectal cancer is by dissection in front of Denonvilliers' fascia. Br J Surg (2004) 2.26
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet (1991) 2.26
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
From quantity to quality: the central cardiac audit database project. Heart (1999) 2.23
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS (1999) 2.23
Parental influences on children's eating behavior and relative weight. J Appl Behav Anal (1983) 2.21
Renal insufficiency in treated essential hypertension. N Engl J Med (1989) 2.17
Palindrome resolution and recombination in the mammalian germ line. Mol Cell Biol (1997) 2.17
Enumeration of absolute numbers of T and B lymphocytes in human blood. Scand J Immunol (1974) 2.16
Ondansetron versus placebo for the control of nausea and vomiting during Caesarean section under spinal anaesthesia. Anaesthesia (1999) 2.15
Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. Lancet (1974) 2.15
Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol (2001) 2.13
Management of carcinomas of the upper gastrointestinal tract. BMJ (1994) 2.12
Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma. J Clin Oncol (2000) 2.12
Cost of treating advanced colorectal cancer: a retrospective comparison of treatment regimens. Eur J Cancer (1996) 2.11
Underascertainment of child abuse mortality in the United States. JAMA (1999) 2.11
Adaptation of a microimmunofluorescence test to the study of human Rickettsia tsutsugamuskh antibody. Am J Trop Med Hyg (1976) 2.10
Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet (1987) 2.09
Assessing the consultation: methods of observing trainees in general practice. Br Med J (Clin Res Ed) (1984) 2.09
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol (1996) 2.08
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer. J Clin Oncol (1995) 2.08
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol (1994) 2.02
Detection of ambulatory ischaemia is not of practical clinical value in the routine management of patients with stable angina. A long-term follow-up study. Eur Heart J (1995) 1.97
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut (2011) 1.96
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer (2004) 1.94
Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis. Clin Immunol Immunopathol (1975) 1.90
Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990-2001. Arch Dis Child (2004) 1.89
CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials. Br J Cancer (2005) 1.81
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80
Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. Immunology (1986) 1.75
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res (1996) 1.74
Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle. Immunology (1986) 1.74
Home-made spacers for bronchodilator therapy in children with acute asthma: a randomised trial. Lancet (1999) 1.73
Multiple myeloma and the anion gap. N Engl J Med (1975) 1.72
Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer. Br J Surg (2010) 1.70
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer (2004) 1.69
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.68